

Squawk on the Street
CNBC
CNBC’s “Squawk on the Street” with Carl Quintanilla, Jim Cramer and David Faber is broadcast from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential Chief Executive Officers and greatest market minds.
Episodes
Mentioned books

Jan 29, 2025 • 43min
Starbucks and T-Mobile CEOs, Chips Extend Rebound from Post-AI Sell-Off, Apple Downgraded Again 1/29/25
Brian Niccol, CEO of Starbucks, discusses the coffee chain’s Q4 results and an innovative turnaround plan focused on enhancing customer experience. Mike Sievert, CEO of T-Mobile US, shares insights on the company's impressive subscriber growth and strong quarterly performance, along with innovative partnerships like their collaboration with SpaceX. The conversation also delves into the chip market's recovery from recent declines and Apple's continued struggles, highlighting broader trends in tech and consumer preferences.

9 snips
Jan 28, 2025 • 42min
SOTS 2nd Hour: State of the AI Arms Race, CNBC Fed Survey, Trump’s Tariff Plans 1/28/25
The podcast dives into the volatile stock market, spotlighting NVIDIA's recovery and Royal Caribbean's success. It analyzes investor sentiment shifts, particularly towards consumer goods, and discusses the impact of AI investments and regulatory changes. Tariff tensions on semiconductors and a leading aerospace company's challenges are explored, alongside insights on economic policies affecting inflation and growth. The competitive AI landscape is examined, alongside developments in the energy sector, including Exxon's proxy fight and sustainable power initiatives.

5 snips
Jan 28, 2025 • 4min
Cramer's Morning Take: Winners of DeepSeek Panic 1/28/25
Jim and Jeff dive into the effects of DeepSeek on tech stocks, highlighting how companies like Meta, Amazon, and Apple are emerging as winners from recent market panic. They discuss the strategic use of low-cost AI to gain a competitive edge and emphasize the significance of maintaining long-term stability during volatility. It's a candid look at shifting market dynamics and what it means for investors.

Jan 28, 2025 • 43min
Stocks Stabilize Following Tech Rout, Boeing CEO on Recovery Plan 1/28/25
The stock market faces a downturn, with the Nasdaq dropping 3%, partly influenced by a Chinese AI startup. Boeing reports its largest annual loss but remains optimistic about future recovery. Insights reveal the booming pet industry through innovative franchises like Dogtopia. A competitive tech landscape emerges, particularly around AI advancements, while energy needs and nuclear power complexities are discussed. Geopolitical factors also play a role in defense sector performance, affecting companies like NVIDIA and AMD.

4 snips
Jan 27, 2025 • 4min
Cramer's Morning Take: DeepSeek Panic 1/27/25
The rise of DeepSeek, a cost-effective Chinese language model, sparks debate on the future of AI investments and energy use. Meanwhile, insights into NVIDIA and Broadcom reveal how AI advancements could shape chip demand. Analysts weigh in on investment trends, suggesting Broadcom may offer a more promising opportunity. It's a lively discussion about the shifting landscape of the semiconductor market!

Jan 27, 2025 • 43min
SOTS 2nd Hour: Breaking down the sell-off – and just what is DeepSeek? 1/27/25
The podcast delves into a stock market sell-off triggered by news about DeepSeek, a new AI model from China. Major tech companies like NVIDIA face significant pressure amidst a reevaluation of U.S. tech dominance. The discussion includes potential impacts on semiconductor and energy sectors, along with insights on the ongoing AI race. The hosts also touch on market dynamics influenced by rising mortgage rates and political tensions, analyzing investment strategies as tech giants approach crucial earnings reports.

Jan 27, 2025 • 42min
Market Sell-Off: China AI Push Sparks Tech Tumble, Nvidia's Double-Digit Slide 1/27/25
A turbulent market kick-started the week as fears of competition from China's AI startup DeepSeek caused a widespread sell-off, especially for tech giants like Nvidia. The discussion highlights the geopolitical implications of emerging foreign technologies and the shift from hardware to open-source models in AI. Amidst this chaos, AT&T posted a surprising earnings beat, and market watchers are keeping a close eye on upcoming economic data and its influence on different sectors. Plus, there’s a celebratory note with Jim cheering for the Eagles' latest victory!

Jan 24, 2025 • 3min
Cramer's Morning Take: Eli Lilly & Novo Nordisk 1/24/25
The discussion dives into the competitive landscape of weight loss drugs, spotlighting Eli Lilly and Novo Nordisk. It highlights Novo Nordisk's promising trial results and compares the effectiveness of their medications. Additionally, there’s a focus on Eli Lilly’s rebound, marked by increasing prescription growth after a slow performance last quarter. Insights into Lilly's new developments, including an emerging amylin molecule, add depth to the conversation.

Jan 24, 2025 • 44min
SOTS 2nd Hour: Venture Global IPO, CSX CEO, and Boeing’s Big Warning 1/24/25
Michael Santoli, Senior Markets Commentator, shares his insights on the record highs in the S&P and the impact of economic data on market trends. Mike Sable, CEO of Venture Global, discusses the company's groundbreaking IPO in the energy sector and its competitive edge in liquefied natural gas production. The conversation touches on CSX's struggles in the coal market, Boeing's warning of significant losses, and broader economic challenges highlighted at the Davos summit, providing a multifaceted view of the current financial landscape.

Jan 24, 2025 • 41min
S&P 500's Record Rally, Meta's $65B AI Investment Plan, Novo Nordisk's Obesity Drug Boost 1/24/25
The discussion kicks off with the S&P 500 hitting a record high, with insights on the performance of the 'Magnificent 7' stocks. Mark Zuckerberg's ambitious $65 billion AI investment plan for Meta sparks intrigue. Novo Nordisk sees a surge thanks to promising results from its obesity drug trials. Additionally, there’s buzz around major earnings reports from American Express and Verizon, and the largest energy IPO in years as Venture Global goes public. The future of technology and healthcare innovations also grabs attention.


